Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery

Current Drug Delivery

Volumn 11, Issue 4, 2014, Pages 521-530

  Sudhakar, Beeravelli ^a   Ravi Varma, J N ^a   Ramana Murthy, K V ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Antifungal; Cholesterol; Franz diffusion apparatus; Gum karaya gel; Liposome; Terbinafine HCl; Unilamellar

Indexed keywords

ALCOHOL; CHOLESTEROL; KARAYA GUM; LIPID; STEARIC ACID; TERBINAFINE; ANTIFUNGAL AGENT; DELAYED RELEASE FORMULATION; EXCIPIENT; GEL; LIPOSOME; NAPHTHALENE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CUTANEOUS DRUG ADMINISTRATION; DRUG FORMULATION; DRUG RETENTION; DRUG STABILITY; EX VIVO STUDY; INFRARED SPECTROSCOPY; LIPID BILAYER; LIPOSOMAL DELIVERY; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANALYSIS; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG DELIVERY SYSTEM; GEL; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; METABOLISM; SKIN; SKIN ABSORPTION; SURFACE PROPERTY; WISTAR RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; GELS; IN VITRO TECHNIQUES; KARAYA GUM; LIPOSOMES; NAPHTHALENES; PARTICLE SIZE; RATS, WISTAR; SKIN; SKIN ABSORPTION; SURFACE PROPERTIES;

EID: 84904742779     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201810666140109113830     Document Type: Article

References (43)

1. Bangham, A. D., Standish, M. M., and Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol., 1965, 13, 238-252.
2. th January 2010.
3. Barry, B. W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci., 2001, 14, 101-114.
4. st Ed. 2003 Pharmaceutical Press, London.
5. El Maghraby, G. M., Williams, A. C., Barry, B. W. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J. Pharm. Pharmacol., 2001, 53, 1311-1322.
6. Mezei, M., Gulasekharam, V. Liposomes-a selective drug delivery system for the topical route of administration: gel dosage form. J. Pharm. Pharmacol., 1982, 34, 473-474.
7. Mezei, M. Liposomes as a skin drug delivery system. In: Breimer, D. D., Speiser, P. (Eds.), Topics in Pharmaceutical Sciences. Elsevier, Amsterdam, 1985 pp. 345-358.
8. Kim, M. K., Chung, S. J., Lee, M. H., Cho, A. R., Shim, C. K. Targeted and sustained delivery of hydrocortisone to normal and stratum corneum removed skin without enhanced skin absorption using a liposome gel. J. Control. Release, 1997, 46, 243-251.
9. Foldvari, M., Gesztes, A., Mezei, M. Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J. Microencapsul., 1990, 7, 479-489.
10. Masini, V., Bonte, F., Meybeck, A., Wepierre, J. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. J. Pharm. Sci., 1993, 82, 17-21.
11. Egbaria, K., Ramachandran, C., Weiner, N., Topical delivery of ciclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. Skin Pharmacol., 1990, 3, 21-28.
12. Honeywell-Nguyen, P. L., Frederik, P. M., Bomans, P. H., Junginger, H. E., Bouwstra, J. A. Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies. Pharm. Res., 2002, 19, 991-997.
13. Karimunnisa S. S., & Atmaram, P. Pawar. Liposomal Delivery Enhances Cutaneous Availabilityof Ciclopirox Olamine. Lat. Am. J. Pharm., 2010, 29 (5), 763-70.
14. Ferreira, L. S., Ramaldes, G. A., Nunan, E. A., Ferreira, L. A. In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis. Drug Dev. Ind. Pharm., 2004, 30, 289-296.
15. Puglia, C., Trombetta, D., Venuti, V., Saija, A., Bonina, F. Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles. J. Pharm. Pharmacol., 2004, 56, 1225-1232.
16. Ramon, E., Alonso, C., Coderch, L., de la Maza, A., Lopez, O., Parra, J. L., Notario, J. Liposomes as alternative vehicles for sun filter formulations. Drug Deliv., 2005, 12, 83-88.
17. Kitagawa, S., Kasamaki, M. Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem. Pharm. Bull., 2006, 54, 242-244.
18. Sakine, T. T., Ozgen, O. Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis. Eur J. Pharm. Sci., 2013, 48, 628-636.
19. Hans, S., Joke, B. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Controlled Release, 1994, 30, (1), 1-15.
20. Helene, E. S and David, L. K. Liposomes in topical drug delivery. Invest. Ophthalmol. Vis. Sci., 1982, 22, (2), 220-227.
21. Abdel-Rhaman, M. S., Soliman, W., Habib, F., Fathalla, D. A new long-acting liposomal topical antifungal formula: human clinical study. Cornea, 2012, 31(2), 126-9.
22. Naeff, R. Feasibility of topical liposome drugs produced on an industrial scale. Adv. Drug Deliv. Rev., 1996, 18, 343-347.
23. Rakesh, P. P., Hardik, H. P. Ashok, H. B. Formulation and evaluation of Carbopol gel containing liposomes of ketoconazole. Int. J. Drug Deliv. Technol., 2009, 1(2), 42-45.
24. Agarwal, R., and Katare, O. P. Preparation and in vitro evaluation of miconazole nitrate loaded topical liposomes, Pharmaceutical Technology North America; 2002, 26, 11; ABI/INFORM Global pg. 48.
25. Demel, R. A., Geurts, van Kessel, W. S., Mand, van D., L. L. M. The properties of polyunsaturated lecithins in monolayers and liposomes and the interactions of these lecithins with cholesterol. Biochimica et Biophysica Acta: Biomembranes 1972, 266, 26-40.
26. Krupa, K. P., Bhavna, H. M. and Kakhans, V. V. Spectrophotometric determination and validation for terbinafine HCl in pur and in tablet dosage form. Der Pharmacia. Lett., 2012, 4, (4) 1119-1122.
27. Du, S., and Deng, Y. Studies on the encapsulation of oxymatrine into liposomes by ethanol injection and pH gradient method. Drug Develop. Indust. Pharm., 2006, 32(7), 791-7.
28. Batzri, S. and Korn, E. D. Single bilayer liposomes prepared without sonication. Biochem. Biophys. Acta, 1973, 298, 1015-1019.
29. Boulmedarat, L., Piel, G., Bochot, A., Lesieur, S., Delattre, L., Fattal, E. Cyclodextrin-Mediated drug release from liposomes dispersed within a bioadhesive gel. Pharm. Res., 2005, 22, 962-971.
30. Touitou, E., Dayan, N., Bergelson, L., Godin, B., Eliaz, M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 2000, 65, 403-418.
31. Gorner, T., Gref, R., Michenot, D., Sommer, F., Tran, M. N., Dellacherie, E., Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymeric matrix. J. Control. Rel., 1999, 57, 259-268.
32. Douglas, S. J., Illum, L., Davis, S. S. and Kreuter, J., Particle size distribution of poly (butyl-2-cyanoacrylate) nanoparticles: l. Influence of physicochemical factors. J. Colloid. M. Interface Sci., 1984, 101, 149-158.
33. Koppel, D. E. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: The method of cumullants. J. Chem. Phys., 1972, 57, 4814-4820.
34. Juanjuan, L., Gan, Hu. Advances in studies of phospholipids as carriers in skin topical applications. J. Biomed. Res., 2007, 21(6), 349-353.
35. Bhalerao, S. S.; Raje, A. Harshal Preparation, Optimization, Characterization, and Stability Studies of Salicylic Acid Liposomes. Drug Dev. Ind. Pharm., 2003, 29(4), 451-467.
36. Moscho, A., Orwar, O., Chiu, D. T., Mool, B. P., Zare, R. N. Rapid preparation of giant unilamellar vesicles. Proc. Natl. Acad. Sci. U. S. A., 1996, 93, 11443-11447.
37. Franz, T. J., Percutaneous absorption. On the relevance of in vitro data. J. Invest. Dermatol., 1975, 67, 190-196.
38. Shah, V. P. Elkins, J. and Skelly J. P. Practical considerations in developing a quality control (in vitro release) procedure for topical drugs. In: Shah, V. P and maibach, H. I (Eds.), Topical drug bioavailability, bioequivalence, and penetration, Plenum Press, New York, 1993, pp. 107-116.
39. Miquel, P., Merce F., and Joan, E. Liposomes obtained by ethanol injection method. Intr J. Pharma., 1993, 95, 51-56.
40. Betageri, G. V. Liposomal encapsulation and stability of dideoxyinosine triphosphate. Drug Dev. Ind. Pharm., 1993, 19, 531-539.
41. Dean, T. P., Hider, R. C. Incorporation of alphaxalone into different types of liposomes. J. Pharm. Pharmacol., 1993, 45, 990-992.
42. Reddy, M. S., Mutalik, S. and Rao, G. V. Preparation and evaluation of minoxidil gels for topical application in alopecia. Indian J. Pharm. Sci., 2006, 432-436.
43. Vaibhav, D., Dinesh, M., Manoj, N., Vikas, J., Jain, N. K. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomed. Nanotechnol. Biol., Med., 2010, 6, 590-596.